The present invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same and to their use for the treatment of cancer and other diseases.Cette invention concerne de nouveaux analogues de chartreusine de formule (I), des compositions pharmaceutiques les contenant et leur utilisation pour traiter le cancer et dautres maladies.